Skip to main content
. 2025 Nov 11;13(11):2749. doi: 10.3390/biomedicines13112749
AK2 Adenylate kinase 2
AML Acute myeloid leukemia
ALL Acute lymphoblastic leukemia
AR Androgen receptor
AROS Active regulator of SIRT1
ASH1L ASH1-like
ATRA All-trans retinoic acid
BET Bromodomain and extraterminal
CN Cytogenetically normal
DDR DNA damage response
DSB Double-strand break
EMT Epithelial–mesenchymal transition
ERα Estrogen receptor alpha
G6PD Glucose-6-phosphate dehydrogenase
HCC Hepatocellular carcinoma
HGSC High-grade serous carcinoma
HK2 Hexokinase 2
H3K36 Histone lysine 36
H3K36me1 Histone lysine 36 monomethylation
H3K36me2 Histone lysine 36 dimethylation
H3K36me3 Histone lysine 36 trimethylation
HMG High mobility group
HNSCC Head and neck squamous cell carcinoma
HR Homologous recombination
IRF3 Interferon regulatory factor 3
JHDM Jumonji C (JmjC) domain-containing histone demethylase
LCA Laryngeal cancer
LUAD Lung adenocarcinoma
LUSC Lung squamous cell carcinoma
MLL1 Mixed lineage leukemia 1
NHEJ Non-homologous end joining
NSL Non-specific lethal
NUP98 Nucleoporin 98
NSD Nuclear receptor-binding SET domain-containing protein
NSRP1 Nuclear speckle splicing regulatory protein 1
PHD Plant homeodomain
PROTAC PROteolysis-Targeting Chimera
PWWP Proline-tryptophan-tryptophan-proline
SAM S-adenosylmethionine
SET Su(var)3-9, enhancer of zeste and trithorax
SETMAR SET domain and mariner transposase fusion gene-containing
SMYD2 SET and MYND domain-containing 2
TCGA The Cancer Genome Atlas
TMB Tumor mutation burden
TNBC Triple-negative breast cancer
VEGF-A Vascular endothelial growth factor-A